Eisai
4523.T
#1968
Rank
โ‚น682.90 B
Marketcap
โ‚น2,421
Share price
0.44%
Change (1 day)
-26.19%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น186.25. In 2022 the company made an earnings per share (EPS) of โ‚น136.73 a decrease over its 2021 EPS that were of โ‚น607.03.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6031.36%
2022โ‚น136.73-77.48%
2021โ‚น607.03-41.88%
2020โ‚น1,044-0.94%
2019โ‚น1,05452.59%
2018โ‚น690.94124.17%
2017โ‚น308.22-49.42%
2016โ‚น609.4337.08%
2015โ‚น444.59-11.75%
2014โ‚น503.76-3.23%
2013โ‚น520.58-18.56%
2012โ‚น639.25-15.51%
2011โ‚น756.62-3.75%
2010โ‚น786.14-1.36%
2009โ‚น796.97